Osimertinib versus standard-of-care EGFR-TKI as first-line treatment for EGFRm advanced NSCLC: FLAURA Japanese subset

Ohe, Y; Imamura, F; Nogami, N; Okamoto, I; Kurata, T; Kato, T; Sugawara, S; Ramalingam, SS; Uchida, H; Hodge, R; Vowler, SL; Walding, A; Nakagawa, K

Ohe, Y (reprint author), Natl Canc Ctr, Dept Thorac Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019; 49 (1): 29

Abstract

Background: The FLAURA study was a multicenter, double-blind, Phase 3 study in which patients with previously untreated epidermal growth factor recept......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索